According to Dentsply Sirona 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -33.31. At the end of 2022 the company had a P/E ratio of -7.20.
Year | P/E ratio | Change |
---|---|---|
2022 | -7.20 | -123.37% |
2021 | 30.8 | -123.55% |
2020 | -131 | -372.95% |
2019 | 48.0 | -677.4% |
2018 | -8.31 | -13.19% |
2017 | -9.57 | -133.65% |
2016 | 28.4 | -15.88% |
2015 | 33.8 | 44.06% |
2014 | 23.5 | 6.01% |
2013 | 22.1 | 24.07% |
2012 | 17.8 | -11.27% |
2011 | 20.1 | 8.87% |
2010 | 18.5 | -2.84% |
2009 | 19.0 | 27.23% |
2008 | 14.9 | -43.58% |
2007 | 26.5 | 27.75% |
2006 | 20.7 | -78.77% |
2005 | 97.6 | 447.15% |
2004 | 17.8 | -12.31% |
2003 | 20.3 | 3.38% |
2002 | 19.7 | -8.26% |
2001 | 21.5 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Danaher DHR | 31.0 | -193.12% | ๐บ๐ธ USA |
3M MMM | -7.84 | -76.46% | ๐บ๐ธ USA |
Align Technology
ALGN | 69.3 | -308.12% | ๐บ๐ธ USA |
Integra LifeSciences IART | 28.5 | -185.71% | ๐บ๐ธ USA |
Biolase
BIOL | -0.0007 | -100.00% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.